Triamcinolone Acetonide

ANDA 87191, held by Alpharma US Pharms. Triamcinolone Acetonide.

As of Nov 15, 2026, ANDA 87191 (Triamcinolone Acetonide), held by Alpharma US Pharms, was first approved by FDA on Sep 8, 1982, with 11 approved supplements and 0 published complete response letters.

First approved: Sep 8, 1982
Supplements approved: 11
Complete response letters: 0

Approvals and New Uses

The original application and every efficacy supplement, newest first; all 12 submissions below

Date	Submission	Status	Documents
Sep 8, 1982	Original application	Approved	None posted

Products

1 strengths and forms

Product	Active ingredient	Marketing
Triamcinolone Acetonide0.025% · lotion;topical	Triamcinolone Acetonide	Discontinued

All 12 submissions, including labeling and manufacturing supplements


Jan 2, 1992	Supplement 20Labeling	Approved	None posted
Mar 21, 1991	Supplement 22Manufacturing	Approved	None posted
Sep 28, 1990	Supplement 21Manufacturing	Approved	None posted
Feb 6, 1990	Supplement 19Labeling	Approved	None posted
Apr 26, 1988	Supplement 14Manufacturing	Approved	None posted
Apr 26, 1988	Supplement 13Manufacturing	Approved	None posted
Oct 16, 1987	Supplement 12Manufacturing	Approved	None posted
Oct 16, 1987	Supplement 10Manufacturing	Approved	None posted
Dec 21, 1983	Supplement 4Manufacturing	Approved	None posted
Nov 16, 1983	Supplement 5Manufacturing	Approved	None posted
Aug 9, 1983	Supplement 3Manufacturing	Approved	None posted
Sep 8, 1982	Original application	Approved	None posted

Identifiers

Application: ANDA 87191
Drugs@FDA: Overview at FDA
Company: Alpharma US Pharmaceuticals

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters